Hana Kostrhunova

20PUBLICATIONS
49CO-AUTHORS
Main group metal chemistryCancer therapy (excl. chemotherapy and radiation therapy)Metal organic frameworksPolymerisation mechanismsSupramolecular chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 23, 2026
Mitochondria-Disrupting Aminocarbyne-DMAP Diiron(I) Complexes Perturb Iron Homeostasis with Marginal ROS Contribution in Cancer Cells.

|Nov 10, 2025
Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models.

Sofia Sharkawy, Sourav Acharya, Hana Kostrhunová

|Dec 02, 2024
A Novel Substituted Benzo[g]quinoxaline-Based Cyclometalated Ru(II) Complex as a Biocompatible Membrane-Targeted PDT Colon Cancer Stem Cell Agent.

Alicia Marco, Jana Kasparkova, Delia Bautista

|Oct 21, 2024
Ni(II) Cylinders Damage DNA in Cancer Cells and Preferentially Bind Y-Shaped DNA Three-Way Junctions Blocking DNA Synthesis.

Jaroslav Malina, Hana Kostrhunova, Viktor Brabec

|Jul 19, 2024
Dicobalt(ii) helices kill colon cancer cells via enantiomer-specific mechanisms; DNA damage or microtubule disruption.

Hualong Song, Hana Kostrhunova, Jakub Cervinka

|Aug 30, 2023
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.

Amrita Sarkar, Vojtech Novohradsky, Moumita Maji

Pageof 4

Frequent Collaborators

19 joint publications

Viktor Brabec

10 joint publications

Jana Kasparkova

8 joint publications

Vojtech Novohradsky

7 joint publications

Lenka Markova